RUSSELL FRANK CO/ - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 94 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q4 2013. The put-call ratio across all filers is 0.34 and the average weighting 0.0%.

Quarter-by-quarter ownership
RUSSELL FRANK CO/ ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2015$40,000
-97.7%
4,694
-96.6%
0.00%
-100.0%
Q2 2015$1,710,000
-4.0%
138,297
-7.8%
0.00%0.0%
Q1 2015$1,782,000
-29.6%
150,049
-34.2%
0.00%
-25.0%
Q4 2014$2,530,000
+46.6%
228,103
+16.0%
0.00%
+33.3%
Q3 2014$1,726,000
+150.9%
196,622
+69.0%
0.00%
+200.0%
Q2 2014$688,000
+34300.0%
116,322
+23883.9%
0.00%
Q3 2013$2,000
+100.0%
485
+385.0%
0.00%
Q2 2013$1,0001000.00%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q4 2013
NameSharesValueWeighting ↓
Lagoda Investment Management, L.P. 1,560,530$17,634,0004.71%
B & T Capital Management DBA Alpha Capital Management 280,113$3,165,0002.22%
Schonfeld Group Holdings LLC 10,000$113,0001.51%
COLUMBIA CAPITAL LLC 117,702$1,331,0001.45%
Portolan Capital Management 607,288$6,862,0001.38%
Price Capital Management, Inc. 118,047$1,334,0001.18%
GARRISON BRADFORD & ASSOCIATES INC 90,700$1,025,0000.93%
Opus Point Partners Management, LLC 72,009$814,0000.80%
EAM Investors, LLC 412,233$4,658,0000.65%
TFS CAPITAL LLC 476,105$5,380,0000.51%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders